longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CLDI

CLDI
----

LongbridgeAI

European stocks "Eleven Arhats" | Astrazeneca fell about 2.2%, Sanofi, GSK, and Novo Nordisk dropped by up to 1.7%

Wallstreetcn
Feb 4, 2025 at 05:26 PM

On Tuesday (February 4th), ASML Holding's stock price in Amsterdam (ASML.NA) closed up 0.35% at €712.40. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) closed down 1.18% at 7592.60 Danish Krone. In addition, AstraZeneca fell 2.18%, Sanofi dropped 1.7%, GSK declined 1.32%, and L'Oréal, Novartis, Roche, and Nestlé also fell between 0.9% and 0.23%. LVMH Group closed up 0.38%, while SAP rose 1.58%

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 24, 2026 at 01:55 PMNovo Nordisk will significantly reduce the price of its weight loss drug in the U.S. next year, with a maximum reduction…
  • Feb 24, 2026 at 11:58 AMNovo Nordisk UBT251 shows impressive phase II clinical data in China, with a weight loss effect of nearly 20%
  • Feb 23, 2026 at 01:57 PMGlobal news you need to know before Monday's U.S. stock market opens
  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday

Related Stocks

AstraZeneca

AstraZeneca

USAZN

-0.51%

Sanofi

Sanofi

USSNYNF

-2.95%

Novo Nordisk AS

Novo Nordisk AS

USNVO

-0.21%